Morgan Stanley’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5K | Buy |
12,194
+2,005
| +20% | +$4.35K | ﹤0.01% | 6561 |
|
|
2025
Q1 | $15.3K | Buy |
10,189
+8,889
| +684% | +$13.3K | ﹤0.01% | 6657 |
|
|
2024
Q4 | $6.54K | Sell |
1,300
-50
| -4% | -$252 | ﹤0.01% | 6935 |
|
|
2024
Q3 | $10.9K | Sell |
1,350
-4,148
| -75% | -$33.4K | ﹤0.01% | 6695 |
|
|
2024
Q2 | $31.7K | Sell |
5,498
-1,658
| -23% | -$9.55K | ﹤0.01% | 6320 |
|
|
2024
Q1 | $85.2K | Buy |
7,156
+4,288
| +150% | +$51K | ﹤0.01% | 6053 |
|
|
2023
Q4 | $53.6K | Buy |
2,868
+1,434
| +100% | +$26.8K | ﹤0.01% | 6358 |
|
|
2023
Q3 | $13.6K | Buy |
1,434
+22
| +2% | +$209 | ﹤0.01% | 6609 |
|
|
2023
Q2 | $20.2K | Sell |
1,412
-289
| -17% | -$4.13K | ﹤0.01% | 6569 |
|
|
2023
Q1 | $26.2K | Sell |
1,701
-27,955
| -94% | -$431K | ﹤0.01% | 6529 |
|
|
2022
Q4 | $398K | Sell |
29,656
-11,631
| -28% | -$156K | ﹤0.01% | 5355 |
|
|
2022
Q3 | $566K | Sell |
41,287
-14,851
| -26% | -$204K | ﹤0.01% | 5208 |
|
|
2022
Q2 | $636K | Sell |
56,138
-53,920
| -49% | -$611K | ﹤0.01% | 5294 |
|
|
2022
Q1 | $1.47M | Sell |
110,058
-44,923
| -29% | -$600K | ﹤0.01% | 4731 |
|
|
2021
Q4 | $2.72M | Buy |
154,981
+117,015
| +308% | +$2.06M | ﹤0.01% | 4326 |
|
|
2021
Q3 | $1.21M | Buy |
37,966
+7,896
| +26% | +$251K | ﹤0.01% | 4922 |
|
|
2021
Q2 | $2.57M | Buy |
+30,070
| New | +$2.57M | ﹤0.01% | 4442 |
|
|
2021
Q1 | – | Sell |
-14,286
| Closed | -$108K | – | 7479 |
|
|
2020
Q4 | $108K | Hold |
14,286
| – | – | ﹤0.01% | 5876 |
|
|
2020
Q3 | $69K | Buy |
+14,286
| New | +$69K | ﹤0.01% | 5588 |
|